Results 161 to 170 of about 2,965,050 (361)
Preoperative short course radiotherapy for squamous cell carcinoma of esophagus revisited: Clinical profile and outcomes from tertiary care cancer centre [PDF]
, 2017 J.R. Kumar Vinaya +4 more
openalex +1 more source
Molecular Oncology, EarlyView.Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Healthcare Choices: 5 Steps to Getting the Medical Care You Want and Need
, 2018 Julie M. Stausmire
openalex +1 more source
Running a Volunteer Program for Palliative Care in a Chinese Hospital: Our Practice and Experience [PDF]
, 2018 Ning Xiaohong, Jie Li, Xiang Yirong
openalex +1 more source
Molecular Oncology, EarlyView.Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Editorial Commentary : Health Care Policies Must Ensure Equitable Access for All Patients [PDF]
Sarav S. Shah
openalex +1 more source
Molecular Oncology, EarlyView.Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Abstracts from Center to Advance Palliative Care National Seminar Palliative Care Everywhere: Bridging the Gaps November 12–14, 2015 San Antonio, TX [PDF]
, 2016 Maria Doll +27 more
openalex +1 more source
Molecular cancer prevention: Intercepting disease
Molecular Oncology, EarlyView.Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source